Clinical Trial Update: Fibrosis Associated Protein Inhibitor (FAPI) Radiotracer-based Imaging to Identify Fibrotic Intestinal Crohn's Disease

View source ↗

Summary

An ongoing clinical trial is evaluating a Fibrosis Associated Protein Inhibitor (FAPI) radiotracer for imaging fibrotic tissue in Crohn's disease. The study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• FAPI radiotracer (Fibrosis-associated protein inhibitor radiotracer)

Snippet

Sponsor: University of Edinburgh | Conditions: Crohn Disease | Status: RECRUITING